J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on May 1, 2004

Papers In Press, published online ahead of print February 1, 2004
J. Lipid Res., doi:10.1194/jlr.M300462-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M300462-JLR200v1
45/5/900    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayatepek, E.
Right arrow Articles by Lehmann, W.-D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayatepek, E.
Right arrow Articles by Lehmann, W.-D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on November 5, 2003
Revised on January 30, 2004
Accepted on January 30, 2004

Synthesis and metabolism of leukotrienes in gamma-glutamyl transpeptidase deficiency

Ertan Mayatepek, Juergen G. Okun, Thomas Meissner, Birgit Assmann, Judith Hammond, Johannes Zschocke, and Wolf-Dieter Lehmann

Department of General Pediatrics, University Children´s Hospital, Duesseldorf 40225

Corresponding Author: mayatepek{at}uni-duesseldorf.de

Leukotrienes (LT)s are active lipid mediators derived in the 5-lipoxygenase pathway. LTC4, the primary cysteinyl leukotriene, is cleaved by gamma-glutamyl transpeptidase (GGT) resulting in LTD4. We studied synthesis and metabolism of LTs in three patients with GGT-deficiency. Leukotrienes were analysed in plasma, urine as well as in stimulated monocytes after HPLC separation by enzyme immunoassays, radioactivity detection and electrospray tandem mass spectrometry. Analysis of LTs in urine of all patients revealed increased concentrations of LTC4 (12.8-17.9 nmol/mol creatinine; controls <0.005 nmol/mol creatinine) whereas LTE4 was below the detection limit (<0.005 nmol/mol creatinine; controls 32.2+-8.6 nmol/mol creatinine). In plasma of one patient LTC4 was found to be increased (17.3 ng/ml; controls 9.6+-0.4 ng/ml) whereas LTD4 and LTE4 were below the detection limit (<0.005 ng/ml). LTB4 was found within normal ranges. In contrast to controls, synthesis of LTD4 as well as LTE4 in stimulated monocytes was below the detection limit (<0.1 ng/106 cells; controls 37.1±4.8; 39.4±5.6 ng/106 cells, respectively). Formation of [3H]-LTD4 from [3H]-LTC4 in monocytes was completely deficient (<0.1%; controls 85±7 %). There was no evidence for any inhibitory activity of LTD4-synthesis in the plasma of a GGT-deficient patient. Our data demonstrate a complete deficiency of LTD4 biosynthesis in patients with a genetic deficiency of GGT. GGT-deficiency represents a new inborn error of cysteinyl-LT-synthesis and provides an unique model to study the pathobiological coherences of LT and glutathione metabolism.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.